Some Characteristics Unique to Depression Before, After Birth
Background traits tied to chronic depression; delivery experience tied to early postpartum depression.
Labor and Delivery
Physician Liable When Vital Information Not Conveyed to Patient, Other Clinicians
As soon as the verdict was delivered, and the jury filed out of the courtroom, the medical practice’s attorney immediately made numerous motions, including for a new trial, for an appeal, to set aside the verdict and to challenge the jury’s award.
ACOG Updates Guidelines for Gestational HTN, Preeclampsia
Second bulletin provides recommendations for management of chronic hypertension in pregnancy
Guidelines Developed for Opioid Use in Vaginal Birth
Guidelines have been developed for use of opioids for uncomplicated spontaneous vaginal birth; the draft consensus guidelines were published online.
Increase Seen in Amphetamine Use in Pregnant Women
Amphetamine use was identified among about 1% of deliveries in the rural West by 2014 to 2015; this number was higher than the incidence of opioid use in most regions.
Timing of Pushing Does Not Impact Spontaneous Vaginal Delivery
The researchers found that the rate of spontaneous vaginal delivery was 85.9 and 86.5% in the immediate and delayed groups, respectively, with no significant difference.
Patient-Directed IV Remifentanil Cuts Epidural Conversions
“Intravenous remifentanil PCA halved the proportion of epidural conversions compared with intramuscular pethidine,” the authors write. “This finding challenges routine pethidine use as standard of care in labor.”
Folic Acid Past First Trimester Does Not Prevent Preeclampsia
The researchers found that preeclampsia occurred in 14.8 and 13.5% of women in the folic acid and placebo groups, respectively (relative risk, 1.10; 95% confidence interval, 0.90 to 1.34; P=.37).
Prophylactic Tranexamic Acid Does Not Cut Postpartum Bleeding
No significant drop in postpartum hemorrhage of 500 ml or more for women receiving oxytocin
Labetalol Use Up for Patients With Preeclampsia and Asthma
The researchers found that patients with asthma used carboprost less frequently than patients with no asthma (11.4 vs 18.0%) compared with intravenous labetalol, which was used more often among patients with a diagnosis of asthma than those without (18.5 vs 16.7%).
